PI
TTOO

Pathlight Investors’s T2 Biosystems, Inc TTOO Stock Holding History

Pathlight Investors’s Portfolio TTOO Stock Details TTOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$117K Buy
+6
New +$141K 0.1% 103

Other funds holding TTOO

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
SM
Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TM
Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Pathlight Investors's TTOO Position: Q4 2018 in Review

Pathlight Investors opened a new position in T2 Biosystems, Inc (TTOO) in Q4 2018: 6 shares worth $117K. The stake represents 0.1% of the portfolio and ranks #103 among its holdings.

84 funds tracked by Wall St. Rank hold TTOO as of Q4 2018.

  • Pathlight Investors held 6 shares of T2 Biosystems, Inc worth $117K as of Q4 2018.
  • T2 Biosystems, Inc was a new Pathlight Investors position in Q4 2018.
  • T2 Biosystems, Inc made up 0.1% of Pathlight Investors's portfolio in Q4 2018, its #103 holding.
  • 84 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q4 2018.

Based on Pathlight Investors's 13F filing for Q4 2018, filed 19 Feb 2019.